News

Healio1d
FDA clears Luminopia for amblyopia in children aged 8 to 12 years old
The FDA cleared Luminopia, a virtual reality-based therapeutic for amblyopia, for use in children aged 8 to 12 years old, ...
InvisionMag5h
NovaSight Achieves Major Milestone: Insurance Coverage Secured for Eye- Tracking-Based Digital Amblyopia Therapy
This marks a pivotal milestone in the transformation of pediatric vision care, significantly expanding access to effective ...
NovaSight Ltd. Achieves Major Milestone: Insurance Coverage Secured for Eye-Tracking-Based Digital Amblyopia Therapy
FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...